Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

Todd Neale

May 03, 2024

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

News Daily News

Brachytherapy Remains an Option for DES In-Stent Restenosis

Yael L. Maxwell

January 12, 2023

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

In-Stent Restenosis Accounts for 10% of All PCIs, Contemporary National Analysis Shows

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

L.A. McKeown

September 24, 2020

News Conference News EuroPCR 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Caitlin E. Cox

May 30, 2018

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

News Daily News

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

L.A. McKeown

July 18, 2017

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

October 12, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

Presentation TCT 2014

Advanced Treatment Options for Recurrent DES Restenosis: From Drugs to Brachytherapy

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Paul S. Teirstein

September 14, 2014

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

May 03, 2013

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

Advertisement

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Brachytherapy Remains an Option for DES In-Stent Restenosis

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Advanced Treatment Options for Recurrent DES Restenosis: From Drugs to Brachytherapy

Contemporary ZES Perform Well in Treating In-Stent Restenosis

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Therapies Take on In-Stent Restenosis with Mixed Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content